» Articles » PMID: 28288174

Poor Phenotype-genotype Association in a Large Series of Patients with Type III Bartter Syndrome

Abstract

Introduction: Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p.Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS.

Methods: Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses.

Results: Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype.

Conclusion: A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort.

Citing Articles

Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation.

Piao Y, Chen C, Wu D, Liu M, Li W, Chen J Mol Genet Metab Rep. 2024; 40:101112.

PMID: 39071140 PMC: 11279331. DOI: 10.1016/j.ymgmr.2024.101112.


Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3.

Garcia-Castano A, Gomez-Conde S, Gondra L, Herrero M, Aguirre M, de la Hoz A Sci Rep. 2023; 13(1):12587.

PMID: 37537162 PMC: 10400606. DOI: 10.1038/s41598-023-38179-6.


Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome.

Palazzo V, Raglianti V, Landini S, Cirillo L, Errichiello C, Buti E Int J Mol Sci. 2022; 23(10).

PMID: 35628451 PMC: 9144947. DOI: 10.3390/ijms23105641.


Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Nunez-Gonzalez L, Carrera N, Garcia-Gonzalez M Int J Mol Sci. 2021; 22(21).

PMID: 34768847 PMC: 8584233. DOI: 10.3390/ijms222111414.


Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the gene linked to Bartter syndrome type III in Spain.

Peces R, Mena R, Peces C, Barruz P, Trujillo H, Carreno A Clin Kidney J. 2021; 14(8):1990-1993.

PMID: 34345425 PMC: 8323134. DOI: 10.1093/ckj/sfab083.


References
1.
Simon D, Bindra R, Mansfield T, Mendonca E, Stone R, Schurman S . Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet. 1997; 17(2):171-8. DOI: 10.1038/ng1097-171. View

2.
Bartter F, PRONOVE P, GILL Jr J, MacCARDLE R . Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962; 33:811-28. DOI: 10.1016/0002-9343(62)90214-0. View

3.
Uchida S, Takeuchi Y, Sasaki S, Hayashi A, Marumo F, Ikeuchi T . Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization. Genomics. 1996; 36(2):372-4. DOI: 10.1006/geno.1996.0479. View

4.
Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N . A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 2002; 63(1):24-32. DOI: 10.1046/j.1523-1755.2003.00730.x. View

5.
Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus G G . Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002; 112(3):183-90. DOI: 10.1016/s0002-9343(01)01086-5. View